Catalog | name | Description | price |
---|---|---|---|
R-R-2839 | Taspoglutide CAS No.275371-94-3 | Taspoglutide/CAS No.275371-94-3 is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM. | price> |
R-R-2840 | Glucagon receptor antagonists-2 CAS No.202917-18-8 | Glucagon receptor antagonists-2/CAS No.202917-18-8 is a highly potent glucagon receptor antagonist. | price> |
R-R-2841 | GLP-1R modulator L7-028 CAS No.2648317-95-5 | GLP-1R modulator L7-028/CAS No.2648317-95-5 is an allosteric modulator enhancing GLP-1 binding to GLP-1R via a transmembrane site (EC50 11.01 ± 2.73 μM). | price> |
R-R-2842 | GLP-1R modulator C16 CAS No.875005-43-9 | GLP-1R modulator C16/CAS No.875005-43-9 is an allosteric modulator enhancing GLP-1 binding to GLP-1R via a transmembrane site (EC50 8.43 ± 3.82 μM). | price> |
R-R-2843 | GLP-1 receptor agonist 2 CAS No.2230197-64-3 | GLP-1 receptor agonist 2/CAS No.2230197-64-3 is a glucagon-like peptide-1 receptor (GLP-1R) agonist. | price> |
R-R-2844 | LSN3318839 CAS No.2764704-18-7 | LSN3318839/CAS No.2764704-18-7 is an orally efficacious positive allosteric modulator of the glucagon-like peptide-1 receptor (GLP-1R). | price> |
R-R-2845 | TT-OAD2 CAS No.2382719-60-8 | TT-OAD2/CAS No.2382719-60-8 is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist with an EC50 of 5 nM. TT-OAD2 has the potential for diabetes treatment. | price> |
R-R-2846 | GLP-1R modulator C5 CAS No.421578-93-0 | GLP-1R modulator C5/CAS No.421578-93-0 is an allosteric modulator enhancing GLP-1 binding to GLP-1R via a transmembrane site (EC50 1.59 ± 0.53 μM). | price> |
R-R-2847 | GRA Ex-25 CAS No.307983-31-9 | GRA Ex-25/CAS No.307983-31-9 is an inhibitor of glucagon receptor, with IC50 of 56 and 55 nM for rat and human glucagon receptors, respectively. | price> |
R-R-2848 | Ecnoglutide CAS No.2459531-73-6 | Ecnoglutide (XW003)/CAS No.2459531-73-6 is a long-acting, cAMP-biased glucagon-like peptide 1 (GLP-1) receptor agonist. Ecnoglutide can be used for research of T2DM and obesity. | price> |